ECMO bridge to recovery vs transplant - Dr. Manjunath M N

Extracorporeal membrane oxygenation - ECMO - is a temporary heart-lung bypass that takes over gas exchange when the patient’s own lungs cannot. At KIMS Electronic City, ECMO is used in two distinct clinical scenarios, and the difference between them shapes everything that follows: the duration of support, the daily clinical questions, the family conversations, and the long-term plan.

Bridge to recovery: when the lungs can heal

In this mode, ECMO is a placeholder. The patient has had an acute lung injury - severe ARDS from pneumonia, influenza, COVID-19, aspiration, drowning, smoke inhalation, post-operative lung failure - and the lung tissue is expected to recover if given the time and the right protective ventilation strategy.

The clinical questions during this phase are:

• Are gas exchange markers (oxygenation, CO₂ clearance) improving on lower ECMO support?
• Can ventilator settings be reduced to lung-protective levels (low tidal volume, low driving pressure)?
• Is imaging showing resolution of consolidation?
• Is the patient awake, mobilising, eating, and free of new infection?

When all these move in the right direction, we start weaning ECMO - reducing flow and sweep gas in steps over 24-72 hours. If the patient maintains adequate gas exchange on the ventilator alone, the cannulas come out. Many patients then go on to a relatively normal recovery, returning home within 2-4 weeks of decannulation.

What we look for in the first week

The trajectory in the first 5-7 days on ECMO is the most important predictor of outcome. A patient whose lung compliance is improving and whose CT shows aerated lung returning is almost certainly going to be a bridge-to-recovery case. A patient with rising fibrosis markers, no improvement in compliance, and progressive consolidation may need to be considered for transplant evaluation in parallel.

Bridge to transplant: when the lungs are not coming back

This is the harder conversation. The patient has end-stage lung disease - IPF, COPD, post-COVID or post-TB fibrosis, primary graft dysfunction after a previous transplant - that has decompensated, and the native lungs have no realistic chance of recovery. ECMO is now keeping the patient alive until a donor is found.

The clinical questions shift:

• Is the patient already an accepted transplant candidate, or do we need to evaluate now?
• What is the realistic waiting time given blood group, body size, and current listing pressure?
• Can we keep the patient mobile, awake, and nutritionally well during the wait?
• Are we preserving the option of bilateral lung transplant (as opposed to single), which has better long-term outcomes in younger patients?

The single most important advance in bridge-to-transplant ECMO has been awake mobilisation. A patient walking the corridor on ECMO arrives at the operating room weeks ahead of a patient who has been sedated and ventilated.

Awake ECMO - why mobilisation matters

A patient lying sedated and ventilated for weeks while waiting for a donor loses muscle mass, develops ICU-acquired weakness, and arrives at the operating room markedly weaker than they would be otherwise. The single most important advance in bridge-to-transplant ECMO has been awake mobilisation: extubating the patient where possible, getting them sitting in a chair, walking with assistance, eating real food, doing physiotherapy.

At our programme, we routinely manage patients on ECMO who are walking the corridor with a physiotherapist, eating meals, communicating with family, and participating in their own care plan. These patients have substantially better post-transplant outcomes - faster extubation, shorter ICU stays, faster rehabilitation.

When the two pathways overlap

In practice, the line between bridge-to-recovery and bridge-to-transplant is rarely drawn at the moment of cannulation. Many patients begin on ECMO with the hope that their lungs will recover, and we revisit the question at fixed intervals - typically day 7, day 14, day 21.

If the lungs are clearly improving by day 7, the plan is recovery. If they are clearly worsening, transplant evaluation begins immediately. If the picture is mixed, we continue protective support and re-assess. The worst outcomes happen when this decision is delayed - a patient who is left on ECMO without a clear plan for 4-6 weeks loses the chance at either outcome.

Why ECMO programmes need transplant programmes (and vice versa)

ECMO without access to transplant is a one-way street: if the lungs do not recover, the patient dies. Transplant without ECMO support means you cannot rescue patients who deteriorate while waiting. The two capabilities should sit in the same centre, run by overlapping teams. That is the model at KIMS Electronic City - the ECMO programme and the lung transplant programme share rounds, share decision-making, and share the same nursing and physiotherapy team. It is one of the reasons outcomes have improved.

For referring physicians: when to ask about ECMO

If you are managing a patient with severe acute respiratory failure (PaO₂/FiO₂ ratio below 80 on optimal ventilation, or rising CO₂ with severe acidosis), or a known end-stage lung disease patient who is deteriorating rapidly, the time to call is before the patient becomes too unstable to transport.

Inter-hospital ECMO retrieval - placing cannulas at the referring hospital and bringing the patient on ECMO - is possible but always higher-risk than initiating ECMO in our own ICU. Earlier conversations almost always lead to better outcomes.

Related reading: our ECMO programme · Who needs a lung transplant? · Lung transplant cost in India · Post lung transplant airway interventions